Heath Lukatch

Heath Lukatch is an experienced leader in the biotechnology and venture capital sectors, currently serving as a Board Member at Engrail Therapeutics, Bicara Therapeutics, Excellergy, and Vaxcyte, as well as a Board Observer at Ceribell. Additionally, Heath Lukatch holds the position of Chairman of the Board at Acrigen Biosciences and Magnus Medical, and serves as the Founder and Managing Partner at Red Tree Venture Capital. Educational qualifications include a Ph.D. in Neuroscience from Stanford University and a B.A. in Biochemistry from the University of California, Berkeley.